Overall Survival With Daratumumab, Bortezomib, and Dexamethasone in Previously Treated Multiple Myeloma (CASTOR): A Randomized, Open-Label, Phase III Trial
暂无分享,去创建一个
P. Sonneveld | A. Chanan-Khan | A. Nooka | M. Munder | T. Masszi | M. Mateos | M. Levin | K. Weisel | I. Špička | A. Spencer | T. Ahmadi | X. Qin | R. Carson | V. Hungria | T. Mark | J. Carey | M. Beksaç | W. Garvin Mayo | X. Gai | I. Spicka